|
|
|
|
MYELODYSPLASTIA
|
|
|
|
MDS
Information
Myelodysplastic
syndromes are a group of diseases characterized
by the body's inability to make healthy
blood cells. Myelodysplasia is referred
to as pre-leukemia because myelodysplastic
syndromes begin in the bone marrow stem
cells and eventually progress to acute myelogenous
leukemia.
Causes:
Benzene is one of few known casues of MDS.
Prior to mid 80's, benzene was found in
varnishes, paint thinners, industrial solvents,
degreassers, and penetrating oils.
Currently, people who work around jet fuel,
petrochemicals, plastics, and rubber manufacturing
are often exposed to benzene.
Types
of MDS:
Refractory Anemia (RA)
Refractory
Anemia with Ringed Sideroblasts (RARS)
Refractory
Anemia with Excess Blasts (RAEB) Refractory
Anemia with Excess Blasts in Transformation
(RAEB-t)
Chronic Myelomonocytic Leukemia (CMML)
Drug
Treatments:
Common
chemotherapy drugs used to treat MDS include
idarubicin, mitoxantrone,
cytosine and daunorubicin.
Clinical
Trail Informtion:
www.cancer.gov
|
|
|
|
|
|
|
Past
cases have involved association of co-counsel. Each
case is unique and involves risk of uncertainty.
Past
success of amount awarded is no guarantee of future
performance.*Cases may be referred or joint counsel
sought. Licensed by the Supreme Court of Texas.
|
|
|
|
myelodysplastic syndrome treatment, myelodysplastic syndrome drugs,
myelodysplastic syndrome prognosis, myelodysplastic syndrome treatment,
myelodysplastic syndrome causes, myelodysplastic cure, myelodysplastic
syndrome stem cell transplant, myelodysplastic syndrome chemotherapy,
myelodysplastic hospital, myelodysplastic research, myelodysplastic
cancer hospital, myelodysplastic information, myelodysplastic
syndromes treatment, myelodysplastic syndromes drugs, myelodysplastic
syndromes prognosis, myelodysplastic syndromes treatment, myelodysplastic
syndromes causes, myelodysplastic cure, myelodysplastic syndromes
stem cell transplant, myelodysplastic syndromes chemotherapy,
myelodysplastic hospital, myelodysplastic research, myelodysplastic
cancer hospital, myelodysplastic information, mds idarubicin,
mds mitoxantrone, mds cytosine, mds daunorubicin, mds help, mds
research, mds information, mds prognosis, mds types, mds drugs,
mds chemotherapy, mds clinical trial information, myelodysplastia
syndrome, myelodysplastic syndrome treatment, myelodysplastic
syndrome drugs, myelodysplastic syndrome prognosis, myelodysplastic
syndrome treatment, myelodysplastic syndrome causes, myelodysplastic
cure, myelodysplastic syndrome stem cell transplant, myelodysplastic
syndrome chemotherapy, myelodysplastic hospital, myelodysplastic
research, myelodysplastic cancer hospital, myelodysplastia information,
myelodysplastic syndromes treatment, myelodysplastic syndromes
drugs, myelodysplastia syndromes prognosis, myelodysplastia syndromes
treatment, myelodysplastia syndromes causes, myelodysplastia cure,
myelodysplastia syndromes stem cell transplant, myelodysplastia
syndromes chemotherapy, myelodysplastia hospital, myelodysplastia
research, myelodysplastia cancer hospital, myelodysplastia information, mds
idarubicin, mds mitoxantrone, mds cytosine, mds daunorubicin,
mds help, mds research, mds information, mds prognosis, mds types,
mds drugs, mds chemotherapy, mds clinical trial information, myelodysplastia
syndrome, |
|
